InterCure Ltd. (INCR) Research

InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.

Market snapshot

Symbol
INCR
Price
$0.93
Day change
-1.09%
Market cap
$154.3M
P/E ratio
-4.22x
52-week range
0.68-1.77
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • American Well Corporation (AMWL)
  • Assertio Holdings, Inc. (ASRT)
  • Biomea Fusion, Inc. (BMEA)
  • CAMP4 Therapeutics Corporation (CAMP)
  • Cardiol Therapeutics Inc. (CRDL)
  • Edap Tms S.a. (EDAP)
  • Fortress Biotech, Inc. (FBIO)
  • MindWalk Holdings Corp. (HYFT)

Recent insider activity

  • Michelson Lennie Grinbaum — trade (0 shares) on 2026-03-18
  • Michelson Lennie Grinbaum — trade (4406 shares) on 2020-03-31
  • Michelson Lennie Grinbaum — trade (15000 shares) on 2024-09-30
  • Granot Alon Shmuel — trade (15000 shares) on 2024-09-30
  • Rabinovich Alexander — trade (0 shares) on 2026-03-18

Open InterCure Ltd. (INCR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.